Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07412496
PHASE2

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

Sponsor: Bausch & Lomb Incorporated

View on ClinicalTrials.gov

Summary

This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.

Official title: A Randomized, Vehicle-Controlled, Double-Masked, Parallel-Group Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

Key Details

Gender

All

Age Range

18 Years - 58 Years

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2026-03-31

Completion Date

2026-10-04

Last Updated

2026-10-22

Healthy Volunteers

No

Interventions

DRUG

Topical Ocular BL1332 low dose

Administered 5 times a day

DRUG

Topical Ocular BL1332 high dose

Administered 5 times a day

DRUG

BL1332 Vehicle ophthalmic vehicle

Administered 5 times a day

Locations (15)

Site 14

Scottsdale, Arizona, United States

Site 3

Long Beach, California, United States

Site 10

Pasadena, California, United States

Site 11

San Diego, California, United States

Site 15

Davie, Florida, United States

Site 13

Brookline, Massachusetts, United States

Site 5

Bloomington, Minnesota, United States

Site 8

Amherst, New York, United States

Site 9

Fargo, North Dakota, United States

Site 6

West Fargo, North Dakota, United States

Site 1

Sioux Falls, South Dakota, United States

Site 2

Cedar Park, Texas, United States

Site 12

Draper, Utah, United States

Site 4

Salt Lake City, Utah, United States

Site 7

Lynchburg, Virginia, United States